Detection of respiratory syncytial virus fusion protein variants between 2009 and 2012 in China

Archives of Virology

Volumn 159, Issue 5, 2014, Pages 1089-1098

  Xia, Qiuling ^a   Zhou, Lili ^a   Peng, Caijing ^a   Hao, Rui ^a   Ni, Ke ^a   Zang, Na ^a   Ren, Luo ^a   Deng, Yu ^b   Xie, Xiaohong ^b   He, Linli ^b   Tian, Daiyin ^b   Wang, Lijia ^a   Huang, Ailong ^a   Zhao, Yao ^b   Zhao, Xiaodong ^b   Fu, Zhou ^b   Tu, Wenwei ^c   Liu, Enmei ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EPITOPE; VIRUS FUSION PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CHILD; CHINA; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFANT; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRESCHOOL CHILD; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIROLOGY;

AMINO ACID SEQUENCE; CHILD; CHILD, PRESCHOOL; CHINA; EPITOPES; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INFANT; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL FUSION PROTEINS;

EID: 84899950342     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-013-1870-9     Document Type: Article

References (39)

1. Adams O, Bonzel L, Kovacevic A, Mayatepek E, Hoehn T, Vogel M (2010) Palivizumab-resistant human respiratory syncytial virus infection in infancy. Clin Infect Dis 51: 185-188.
2. Agenbach E, Tiemessen CT, Venter M (2005) Amino acid variation within the fusion protein of respiratory syncytial virus subtype A and B strains during annual epidemics in South Africa. Virus Genes 30: 267-278.
3. Andabaka T, Nickerson JW, Rojas-Reyes MX, Rueda JD, Bacic Vrca V, Barsic B (2013) Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev 4: CD006602.
4. Anderson LJ, Hierholzer JC, Bingham PG, Stone YO (1985) Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay. J Clin Microbiol 22: 1050-1052.
5. Botosso VF, Zanotto PM, Ueda M, Arruda E, Gilio AE, Vieira SE, Stewien KE, Peret TC, Jamal LF, Pardini MI, Pinho JR, Massad E, Sant'anna OA, Holmes EC, Durigon EL (2009) Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus. PLoS Pathog 5: e1000254.
6. Brandenburg AH, de Waal L, Timmerman HH, Hoogerhout P, de Swart RL, Osterhaus AD (2000) HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein. J Virol 74: 10240-10244.
7. Costello HM, Ray WC, Chaiwatpongsakorn S, Peeples ME (2012) Targeting RSV with vaccines and small molecule drugs. Infect Disord Drug Targets 12: 110-128.
8. Day ND, Branigan PJ, Liu C, Gutshall LL, Luo J, Melero JA, Sarisky RT, Del Vecchio AM (2006) Contribution of cysteine residues in the extracellular domain of the F protein of human respiratory syncytial virus to its function. Virol J 3: 34.
9. De Baets S, Schepens B, Sedeyn K, Schotsaert M, Roose K, Bogaert P, Fiers W, Saelens X (2013) Recombinant influenza virus carrying the RSV F85-93 CTL epitope reduces respiratory syncytial virus replication in mice. J Virol.
10. Gonzalez-Reyes L, Ruiz-Arguello MB, Garcia-Barreno B, Calder L, Lopez JA, Albar JP, Skehel JJ, Wiley DC, Melero JA (2001) Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci USA 98: 9859-9864.
11. Jones BG, Sealy RE, Rudraraju R, Traina-Dorge VL, Finneyfrock B, Cook A, Takimoto T, Portner A, Hurwitz JL (2012) Sendai virus-based RSV vaccine protects African green monkeys from RSV infection. Vaccine 30: 959-968.
12. Kanai Y, Boonsathorn N, Chittaganpitch M, Bai G, Li Y, Kase T, Takahashi K, Okuno Y, Jampangern W, Ikuta K, Sawanpanyalert P (2010) The impact of antigenic drift of influenza A virus on human herd immunity: sero-epidemiological study of H1N1 in healthy Thai population in 2009. Vaccine 28: 5437-5444.
13. Kim YK, Choi EH, Lee HJ (2007) Genetic variability of the fusion protein and circulation patterns of genotypes of the respiratory syncytial virus. J Med Virol 79: 820-828.
14. Liu C, Day ND, Branigan PJ, Gutshall LL, Sarisky RT, Del Vecchio AM (2007) Relationship between the loss of neutralizing antibody binding and fusion activity of the F protein of human respiratory syncytial virus. Virol J 4: 71.
15. Martinello RA, Chen MD, Weibel C, Kahn JS (2002) Correlation between respiratory syncytial virus genotype and severity of illness. J Infect Dis 186: 839-842.
16. McLellan JS, Chen M, Leung S, Graepel KW, Du X, Yang Y, Zhou T, Baxa U, Yasuda E, Beaumont T, Kumar A, Modjarrad K, Zheng Z, Zhao M, Xia N, Kwong PD, Graham BS (2013) Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340: 1113-1117.
17. Moore ML, Chi MH, Luongo C, Lukacs NW, Polosukhin VV, Huckabee MM, Newcomb DC, Buchholz UJ, Crowe JE Jr, Goleniewska K, Williams JV, Collins PL, Peebles RS Jr (2009) A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J Virol 83: 4185-4194.
18. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simoes EA, Rudan I, Weber MW, Campbell H (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375: 1545-1555.
19. Ou SY, Lin GY, Wu Y, Lu XD, Lin CX, Zhou RB (2009) Viral pathogens of acute lower respiratory tract infection in hospitalized children from East Guangdong of China. Zhongguo Dang Dai Er Ke Za Zhi 11: 203-206.
20. Papadopoulos NG, Gourgiotis D, Javadyan A, Bossios A, Kallergi K, Psarras S, Tsolia MN, Kafetzis D (2004) Does respiratory syncytial virus subtype influences the severity of acute bronchiolitis in hospitalized infants? Respir Med 98: 879-882.
21. Papenburg J, Carbonneau J, Hamelin M-È, Isabel S, Bouhy X, Ohoumanne N, Déry P, Paes BA, Corbeil J, Bergeron MG, De Serres G, Boivin G (2012) Molecular evolution of respiratory syncytial virus fusion gene, Canada, 2006-2010. Emerg Infect Dis 18: 120-124.
22. Perkins SM, Webb DL, Torrance SA, El Saleeby C, Harrison LM, Aitken JA, Patel A, DeVincenzo JP (2005) Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus. J Clin Microbiol 43: 2356-2362.
23. Plows DJ, Pringle CR (1995) Variation in the fusion glycoprotein gene of human respiratory syncytial virus subgroup A. Virus Genes 11: 37-45.
24. Rawling J, Garcia-Barreno B, Melero JA (2008) Insertion of the two cleavage sites of the respiratory syncytial virus fusion protein in Sendai virus fusion protein leads to enhanced cell-cell fusion and a decreased dependency on the HN attachment protein for activity. J Virol 82: 5986-5998.
25. Ren XW, Ju LW, Yang JX, Lv XH, Jiang LF, Zhao NQ, Jiang QW (2011) Antigenic and genetic variation in the hemagglutinins of H1N1 and H3N2 human influenza a viruses in the Shanghai area from 2005 to 2008. J Med Virol 83: 1113-1120.
26. Resch B, Michel-Behnke I (2013) Respiratory syncytial virus infections in infants and children with congenital heart disease: update on the evidence of prevention with palivizumab. Curr Opin Cardiol 28: 85-91.
27. Rock MT, Crowe JE Jr (2003) Identification of a novel human leucocyte antigen-A*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein. Immunology 108: 474-480.
28. Schlender J, Zimmer G, Herrler G, Conzelmann KK (2003) Respiratory syncytial virus (RSV) fusion protein subunit F2, not attachment protein G, determines the specificity of RSV infection. J Virol 77: 4609-4616.
29. Shao HY, Lin YW, Yu SL, Lin HY, Chitra E, Chang YC, Sia C, Chong P, Hsu MT, Wei OL, Chow YH (2011) Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse. PLoS One 6: e25500.
30. Smith EC, Popa A, Chang A, Masante C, Dutch RE (2009) Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J 276: 7217-7227.
31. Sun Z, Pan Y, Jiang S, Lu L (2013) Respiratory syncytial virus entry inhibitors targeting the F protein. Viruses 5: 211-225.
32. Tripp R, Jang J-E, Lee J-B, Kim K-H, Park SM, Shim B-S, Cheon IS, Song MK, Chang J (2011) Evaluation of protective efficacy of respiratory syncytial virus vaccine against A and B subgroup human isolates in Korea. PLoS One 6: e23797.
33. Xie ZD, Xiao Y, Liu CY, Hu YH, Yao Y, Yang Y, Qian SY, Geng R, Wang JW, Shen KL (2011) Three years surveillance of viral etiology of acute lower respiratory tract infection in children from 2007 to 2010. Zhonghua Er Ke Za Zhi 49: 745-749.
34. Zhang Zy, Du Ln, Chen X, Zhao Y, Liu Em, Yang Xq, Zhao Xd (2010) Genetic variability of respiratory syncytial viruses (RSV) prevalent in Southwestern China from 2006 to 2009: emergence of subgroup B and A RSV as dominant strains. J Clin Microbiol 48: 1201-1207.
35. Zhao X (2004) Respiratory syncytial virus escape mutant derived in vitro resists palivizumab prophylaxis in cotton rats. Virology 318: 608-612.
36. Zhao X, Sullender WM (2005) In vivo selection of respiratory syncytial viruses resistant to palivizumab. J Virol 79: 3962-3968.
37. Zhu Q, McAuliffe JM, Patel NK, Palmer-Hill FJ, Yang CF, Liang B, Su L, Zhu W, Wachter L, Wilson S, MacGill RS, Krishnan S, McCarthy MP, Losonsky GA, Suzich JA (2011) Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab. J Infect Dis 203: 674-682.
38. Zhu Q, Patel NK, McAuliffe JM, Zhu W, Wachter L, McCarthy MP, Suzich JA (2012) Natural polymorphisms and resistance-associated mutations in the fusion protein of respiratory syncytial virus (RSV): effects on RSV susceptibility to palivizumab. J Infect Dis 205: 635-638.
39. Zimmer G, Budz L, Herrler G (2001) Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences. J Biol Chem 276: 31642-31650.